Drug Profile
Research programme: retinoic acid metabolising enzyme blockers - Bioenvision
Alternative Names: RAMBA - BioenvisonLatest Information Update: 16 Mar 2007
Price :
$50
*
At a glance
- Originator Bioenvision
- Class
- Mechanism of Action Retinoic acid metabolism modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Leukaemia; Prostate cancer
Most Recent Events
- 05 Nov 2003 Preclinical trials in Leukaemia in USA (unspecified route)
- 05 Nov 2003 Preclinical trials in Prostate cancer in USA (unspecified route)